Acadia Pharmaceuticals ACAD Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept acad:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's increase decrease in operating lease liabilities?
- Acadia Pharmaceuticals (ACAD) reported increase decrease in operating lease liabilities of -$2.18M in Q1 2026.
- How has Acadia Pharmaceuticals's increase decrease in operating lease liabilities changed year-over-year?
- Acadia Pharmaceuticals's increase decrease in operating lease liabilities decreased by 691.6% year-over-year, from $369K to -$2.18M.
- What is the long-term trend for Acadia Pharmaceuticals's increase decrease in operating lease liabilities?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's increase decrease in operating lease liabilities has grown at a 4.6% compound annual growth rate (CAGR), from -$5.43M to -$6.52M.
- What does increase decrease in operating lease liabilities mean?
- This represents the net change in lease liabilities associated with operating leases, reflecting the cash payments made to reduce lease obligations versus new lease liabilities recognized. It provides insight into the company's ongoing contractual obligations for facilities or equipment. Tracking this helps investors assess the company's fixed cost structure and liquidity requirements.